Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Paying for statins.

× No keyword cloud information.

9 in total

1. Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Authors: D M Pickin; C J McCabe; L E Ramsay; N Payne; I U Haq; W W Yeo; P R Jackson
Journal: Heart Date: 1999-09 Impact factor: 5.994

2. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors:
Journal: Heart Date: 1998-12 Impact factor: 5.994

3. Statins: underused by those who would benefit.

Authors: S B Hulley; D Grady; W S Browner
Journal: BMJ Date: 2000-10-21

Review 4. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors: M R Law; N J Wald; A R Rudnicka
Journal: BMJ Date: 2003-06-28

5. Guidelines on preventing cardiovascular disease in clinical practice.

Authors: R Jackson
Journal: BMJ Date: 2000-03-11

Review 6. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.

Authors: D Marks; D Wonderling; M Thorogood; H Lambert; S E Humphries; H A Neil
Journal: Health Technol Assess Date: 2000 Impact factor: 4.014

7. Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey.

Authors: I U Haq; L E Ramsay; E J Wallis; C G Isles; L D Ritchie; P R Jackson
Journal: Heart Date: 2001-09 Impact factor: 5.994

8. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.

Authors: M Pignone; C Phillips; C Mulrow
Journal: BMJ Date: 2000-10-21

9. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors: J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal: JAMA Date: 1998-05-27 Impact factor: 56.272

9 in total

3 in total

Review 1. Withholding policies from patients restricts their autonomy.

Authors: Charlotte Williamson
Journal: BMJ Date: 2005-11-05

Review 2. Cost effectiveness of statins in coronary heart disease.

Authors: Oscar H Franco; Anna Peeters; Caspar W N Looman; Luc Bonneux
Journal: J Epidemiol Community Health Date: 2005-11 Impact factor: 3.710

3. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.

Authors: Jaume Marrugat; Isaac Subirana; Eva Comín; Carmen Cabezas; Joan Vila; Roberto Elosua; Byung-Ho Nam; Rafel Ramos; Joan Sala; Pascual Solanas; Ferran Cordón; Joan Gené-Badia; Ralph B D'Agostino
Journal: J Epidemiol Community Health Date: 2007-01 Impact factor: 3.710

3 in total